Fig. 2

Disease progression and relapse free at last visit (intention-to-treat population), for whom these data were available (aged 41–50 years, n = 301; aged > 50 years, n = 135)

Disease progression and relapse free at last visit (intention-to-treat population), for whom these data were available (aged 41–50 years, n = 301; aged > 50 years, n = 135)